5Kasama S,Kumakura H,Kumakura H. Effects of candesartan on cardiac sympathetic nerve activity in patients with congestive heart failure and preserved left ventricular ejection fraction [ J ]. Journal of the America College of Cardiology, 2005,45 ( 5 ) : 661-667.
5Moe SM,Drueke TB.Management of secondary hyperparathyroidism:the importance and the challenge of controlling parathyroid hormone levels without elevation calcium,phosphorus and calcium-phosphorus product.Am J Nephrol,2003,23(6):369-379
6William WA,Magro CM.Calciphylaxis:emerging concepts in prevention,diagnosis and tretment.Semi Dial,2002,15(3):172-180
7Consensus recommendations for the management of chronic heart failure.On behalf of the membership of the advisory council to improve outcomes nationwide in heart failure[].The American Journal of Cardiology.1999
4Kasama S,Kumakura H,Kumakura H.Effects of candesartan on cardiac sympathetic nerve activity in patients with congestive heart failure and preserved left ventricular ejection fraction.J Am Coll Cardiol,2005,4 5 (5):661-667.
7Kasama S,Kumakura H.Effects of candesartan oncardiac sympathetic nerve activity in patients with congestive heart failure and preserved1eft ventricular ejection frac-tion[J].J Am Coll Cardiol,2005,45(5):661-667.
